Trial of Endocrine Against Locoregional Therapy First in Postmenopausal Women With Early Breast Cancer

NCT00908531 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

123

Enrollment

OTHER

Sponsor class

Stopped Poor recruitement

Conditions

Operable Breast Neoplasms

Interventions

DRUG: letrozole (Femara)

Sponsor

Danish Breast Cancer Cooperative Group

Collaborators

[object Object]
[object Object]
[object Object]